June 15, 2009

HELIX BIOPHARMA ANNOUNCES Q3 2009 FINANCIAL RESULTS AND PROVIDES PRODUCT DEVELOPMENT UPDATE (PDF)

(Aurora, Ontario) – Helix BioPharma Corp. (“Helix” or the “Company”), (TSX, FSE: “HBP”) today announced its product development progress, quarterly highlights and financial results for the third quarter of fiscal 2009, ended April 30, 2009.